Disclosure – Transfers of Value and Collaborative Working
Transfers of Value
Zambon UK is committed to adhering to the requirements of the ABPI Code of Practice, including the transparency obligations for documenting and disclosing Transfers of Value (ToV) made to health professionals, other relevant decision makers, healthcare organisations, institutions, etc. and payments made to patient organisations and the public, including patients and journalists.
Zambon UK and society as a whole has an interest in the relevant data being published on the Disclosure UK platform, in order to increase transparency in the industry and ensure that patients and the public can have confidence that the relationship between pharmaceutical companies and healthcare professionals and other individuals and organisations is open and ethical.
It is open about its activities and interactions with all stakeholders and encourages its stakeholders to act with the same openness.
‘Transfer of value’ means a direct or indirect transfer of value, whether in cash, in-kind or otherwise, made, whether for promotonal purposes or otherwise, in connecGon with the development or sale of medicines. A direct transfer of value is one made directly by a company for the benefit of a recipient. An indirect transfer of value is one made on behalf of a company for the benefit of a recipient or through an intermediate and where the company knows or can idenGfy the recipient that will benefit from the transfer of value
Zambon’s transfers of value may include:
- Registration fees and expenses from supporting healthcare professionals to attend scientific events / meetings (made directly to the health professional or via a healthcare organisation)*
- Fees and expenses paid to healthcare professionals or other relevant decision makers for consultancy purposes*
- Sponsorship, donations, grants, or contracted service fees and/or expenses, to healthcare organisations
- Collaborative working with healthcare organisations
- Research and Development (R&D) activities
- Sponsorship, donations, grants, or contracted service fees and/or expenses, to patient organisations
- Fees and expenses paid to members of the public (including patients and journalists) for consultancy purposes*
*Zambon UK relies on explicit consent to disclose ToV data for individual health professionals and other relevant decision makers. If consent is not provided, values will be disclosed in aggregate
Publication of values
The transfer of values are published on the following website
Disclosure UK is the searchable, online database showing payments and benefits in kind made to UK healthcare professionals (HCPs) and healthcare organisations (HCOs) for working in partnership with the pharmaceutical industry.
Relevant transfers of value to patient organisations and any transfers to members of the public, patients and journalists shall be accessible here if applicable:
Collaborative Working
Zambon aims to establish partnerships which both improve patient care and add value to the NHS, in compliance with best practice guidance from the Department of Health and the Association for British Pharmaceutical Industry (ABPI) Code of Practice. If Zambon has engaged in collaborative working, it will be listed below: